stockportfolio.pro
Stocks / BAX vs PODD
BAX vs PODD
Baxter International Inc. and Insulet Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Baxter International Inc. (BAX) | Insulet Corporation (PODD) | |
|---|---|---|
| Market cap | $10.7B | $10.3B |
| Revenue (latest FY) | $11.24B | $2.71B |
| Net income (latest FY) | $-957.00M | $247.10M |
| Revenue growth (5y CAGR) | -0.7% | 24.5% |
| Net margin | -8.5% | 9.1% |
| Return on equity | -15.6% | 16.3% |
| P/E ratio | — | 34.6 |
| Dividend yield | 1.0% | — |
| Profitable years (of last 10) | 7 | 8 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BAX — free Open PODD — freeFrequently asked questions
Which is bigger, BAX or PODD?
Baxter International Inc. is larger by market capitalization — $10.7B versus $10.3B.
Which grows faster, BAX or PODD?
Over the last five fiscal years, Insulet Corporation grew revenue faster — 24.5%/yr versus -0.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.